Home Newsfeeds Citigroup Downgrades ZIM Integrated Shipping to Neutral

Citigroup Downgrades ZIM Integrated Shipping to Neutral

Citigroup analyst Sathish Sivakumar downgrades ZIM Integrated Shipping (NYSE:ZIM) from Buy to Neutral.

byBenzinga Newsdesk

August 23, 2022

1 minute read

Citigroup analyst Sathish Sivakumar downgrades ZIM Integrated Shipping (NYSE:ZIM) from Buy to Neutral.

Noodles & Co Stock Tumbles: CFO Resigns, Analyst Professed A Distaste On Low Traffic

By Lekha Gupta

May 19, 12:36 PM

Stephens & Co analyst Joshua Long downgraded Noodles & Co (NASDAQ:NDLS) to Equal-Weight from Overweight at a reduced price target of $5…

NDLS

Analyst Ratings

Selective Insurance Gr Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)

By Benzinga Insights

April 15, 1:00 PM

In the latest quarter, 4 analysts provided ratings for Selective Insurance Gr (NASDAQ:SIGI), showcasing a mix of bullish…

SIGI

News

Acadia Pharmaceuticals Confirms Delaware District Court Issued A Claim Construction Order In Favor Of Acadia Regarding Its ‘721 Formulation Patent For NUPLAZID®

By Benzinga Newsdesk

December 14, 3:20 AM

- This is the second patent ruling issued today from the Court in favor of Acadia Acadia Pharmaceuticals Inc. (NASDAQ:ACAD) today announced that the U.S. District Court for the District of Delaware has issued a

ACAD

Analyst Ratings

Where Hudson Pacific Properties Stands With Analysts

By Benzinga Insights

September 9, 11:11 AM

Hudson Pacific Properties (NYSE:HPP) has observed the following analyst ratings within the last quarter:

HPP

Citigroup Downgrades ZIM Integrated Shipping to Neutral

Related Posts

Noodles & Co Stock Tumbles: CFO Resigns, Analyst Professed A Distaste On Low Traffic

Selective Insurance Gr Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)

Acadia Pharmaceuticals Confirms Delaware District Court Issued A Claim Construction Order In Favor Of Acadia Regarding Its ‘721 Formulation Patent For NUPLAZID®

Where Hudson Pacific Properties Stands With Analysts